Form 4: Haemonetics Corp Executive Stewart W. Strong Sells Shares Under 10b5-1 Plan
SEC Form 4
Stewart W. Strong, President of Global Hospital at Haemonetics Corp, sold 4,312 shares of common stock at $91.15 per share on July 26, 2024, under a pre-existing 10b5-1 trading plan.
Summary
- On July 26, 2024, Stewart W. Strong, President, Global Hospital at Haemonetics Corp, sold 4,312 shares of common stock.
- The sale was executed at a price of $91.15 per share.
- The transaction was conducted under a pre-existing 10b5-1 trading plan established on June 12, 2023.
- Following the transaction, Mr. Strong beneficially owns 18,196 shares of Haemonetics Corp, including unvested restricted stock units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the transaction is a routine sale under a pre-existing plan and doesn't necessarily indicate a positive or negative outlook for the company.
Industry Context
Insider sales are a common occurrence and are often related to personal financial planning rather than a reflection of the company's prospects. The use of a 10b5-1 plan suggests the sale was pre-planned.
Stakeholder Impact
- The sale may have a minor impact on shareholders due to the small volume of shares sold.
Key Dates
| Date | Description |
|---|---|
| June 12, 2023 | Date of the existing 10b5-1 trading plan |
| July 26, 2024 | Date of the transaction (stock sale) |
| July 29, 2024 | Date of signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.